# RAG outputs on 5 dev queries

Model: `Qwen/Qwen3-4B-Instruct-2507` (greedy). Retrieval: parser v1.1 + RRF, top-5 as context. Grades come from qrels v1.2 and were NOT shown to the model.

## Q01: Recruiting NSCLC trials involving pembrolizumab

Parsed filters: `{"status": ["RECRUITING"]}`

| # | NCT ID | Title | Status | Phase | Grade (for checking) |
|---|---|---|---|---|---|
| 1 | NCT06195527 | PEMBRO-K : Evaluation of Pembrolizumab Therapeutic Pharmacological Monitoring Be | RECRUITING | NA | 2 |
| 2 | NCT06709859 | Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR S | RECRUITING | PHASE2 | 0 |
| 3 | NCT05761223 | A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and  | RECRUITING | PHASE1; PHASE2 | 1 |
| 4 | NCT03829254 | A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients Wi | RECRUITING | PHASE1; PHASE2 | 0 |
| 5 | NCT07061379 | Patient Reported Outcome Measurements (PROMs) Impact on Clinical Outcome in firs | RECRUITING | NA | 2 |

**Answer:**

[3] NCT05761223: A Phase I/II study investigating the safety and efficacy of FB849 in combination with pembrolizumab in advanced solid tumors, including NSCLC. [NCT05761223](https://clinicaltrials.gov/study/NCT05761223)  
[5] NCT07061379: A study evaluating patient-reported outcomes in first-line NSCLC treated with chemotherapy plus pembrolizumab. [NCT07061379](https://clinicaltrials.gov/study/NCT07061379)  

Partial matches:  
[1] NCT06195527 does not list pembrolizumab as an intervention.  
[2] Uses afatinib, not pembrolizumab.  
[4] Includes pembrolizumab but in a broader solid tumor population, not specifically NSCLC.

Cited: ['NCT05761223', 'NCT07061379', 'NCT06195527'] · grades of cited trials: {'NCT05761223': '1', 'NCT07061379': '2', 'NCT06195527': '2'} · invalid citations: [] · says no match: False · 7.97 s

## Q11: Keytruda trials in lung cancer

Parsed filters: `{}`

| # | NCT ID | Title | Status | Phase | Grade (for checking) |
|---|---|---|---|---|---|
| 1 | NCT07188480 | The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients | RECRUITING | NA | 0 |
| 2 | NCT03419286 | Transformation Into Small Cell Lung Cancer : a Mode of Resistance to Treatment | COMPLETED | NA | 0 |
| 3 | NCT07315672 | Acupressure for Cough in Lung Cancer Survivors | RECRUITING | NA | 0 |
| 4 | NCT03658083 | Exploring Robotic-assisted Thoracic Surgery for Lung Cancer | COMPLETED | NA | 0 |
| 5 | NCT02607605 | A Prospective, Observational Trial on the Diagnostic and Prognostic of LM | UNKNOWN | NA | 0 |

**Answer:**

None of the retrieved trials match this query. The listed trials do not include any studies of Keytruda (pembrolizumab) in lung cancer. While some trials address non-small cell lung cancer (NSCLC) or lung cancer in general, they do not involve Keytruda as an intervention.

Cited: [] · grades of cited trials: {} · invalid citations: [] · says no match: True · 2.21 s

## Q24: Phase 3 trials of lecanemab for early Alzheimer's disease

Parsed filters: `{"phase": ["PHASE3"]}`

| # | NCT ID | Title | Status | Phase | Grade (for checking) |
|---|---|---|---|---|---|
| 1 | NCT06989697 | Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes | RECRUITING | PHASE3 | 0 (verified zero-answer query) |
| 2 | NCT03493854 | A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous A | COMPLETED | PHASE3 | 0 (verified zero-answer query) |
| 3 | NCT03108846 | Escitalopram for Agitation in Alzheimer's Disease | ACTIVE_NOT_RECRUITING | PHASE3 | 0 (verified zero-answer query) |
| 4 | NCT02107703 | A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormo | ACTIVE_NOT_RECRUITING | PHASE3 | 0 (verified zero-answer query) |
| 5 | NCT02683746 | Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes  | COMPLETED | PHASE3 | 0 (verified zero-answer query) |

**Answer:**

None of the retrieved trials match this query. The trials listed do not involve lecanemab, and none are focused on early Alzheimer's disease in a Phase 3 trial. The closest match is NCT03108846, which studies escitalopram for agitation in dementia, not lecanemab for early Alzheimer's disease.

Cited: ['NCT03108846'] · grades of cited trials: {'NCT03108846': '0 (verified zero-answer query)'} · invalid citations: [] · says no match: True · 2.52 s

## Q03: Recruiting trials for Alzheimer's disease

Parsed filters: `{"status": ["RECRUITING"]}`

| # | NCT ID | Title | Status | Phase | Grade (for checking) |
|---|---|---|---|---|---|
| 1 | NCT06989697 | Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes | RECRUITING | PHASE3 | 0 |
| 2 | NCT06914284 | Apathy-related Neurobehavioral Markers of Cognitive Decline in Old-age Bipolar D | RECRUITING | NA | 0 |
| 3 | NCT07580183 | Spatial Scene Recognition Memory in Epilepsy Surgery | RECRUITING | NA | 0 |
| 4 | NCT06818682 | Reduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A  | RECRUITING | PHASE2 | 0 |
| 5 | NCT05901493 | Category Learning Retention in Adults With and Without Developmental Language Di | RECRUITING | NA | 0 |

**Answer:**

None of the retrieved trials match this query. None of the trials listed have Alzheimer's disease as a condition. The closest related conditions are cognitive ability, memory disorders, and cognitive decline, but none specifically target Alzheimer's disease.

Cited: [] · grades of cited trials: {} · invalid citations: [] · says no match: True · 1.59 s

## Q20: Parkinson's disease trials that are not yet recruiting

Parsed filters: `{"status": ["NOT_YET_RECRUITING"]}`

| # | NCT ID | Title | Status | Phase | Grade (for checking) |
|---|---|---|---|---|---|
| 1 | NCT06809556 | Association of EEG Parameters with Postoperative Delirium in Patient's with Park | NOT_YET_RECRUITING | NA | 2 |
| 2 | NCT07396922 | Assessment of Safety and Effectiveness of Spatial StimelMD (SSMD) in Subjects Wi | NOT_YET_RECRUITING | NA | 0 |
| 3 | NCT06859229 | New Technological Pathway for Gait Rehabilitation | NOT_YET_RECRUITING | NA | 0 |
| 4 | NCT07720479 | Intranasal Insulin for Postoperative Delirium in Older Patients With T2DM | NOT_YET_RECRUITING | NA | 0 |
| 5 | NCT06230705 | Community Intervention to Improve CVD Risk Factor Control in Young American Indi | NOT_YET_RECRUITING | NA | 0 |

**Answer:**

None of the retrieved trials match this query. While several trials involve Parkinson's disease, only one (NCT06809556) includes Parkinson's disease as a condition, but it focuses on postoperative delirium and EEG monitoring, not a direct Parkinson's disease intervention. The other trials do not study Parkinson's disease or are not focused on Parkinson's-specific treatments or interventions. Therefore, no trial that is specifically for Parkinson's disease and not yet recruiting fits the query.

Cited: ['NCT06809556'] · grades of cited trials: {'NCT06809556': '2'} · invalid citations: [] · says no match: True · 3.42 s

